Discover 833 paid clinical trials in Alberta . Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 833
SW-RCT Implementation of Canadian Syncope Risk Score Based Practice Recommendations
A Study to See if hENT1 Testing on Tumour Tissue Can Predict Response to Treatment With Gemcitabine Chemotherapy and if a Different Chemotherapy Called FOLFOX is Better Than Gemcitabine in Metastatic Pancreas Cancer
for
Metastatic Pancreas Cancer
Location: Edmonton
Sponsor: AHS Cancer Control Alberta
Sex: All
Age: 18+
Code: NCT01586611
Phase3, Recruiting
Nuclear Imaging for Subtype Diagnosis of Primary Aldosteronism
for
Primary Aldosteronism
Location: Calgary
Sponsor: University of Calgary
Sex: All
Age: 18+
Code: NCT05472493
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer
Location: New Haven CT, Brooklyn NY, New York NY, Montreal,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06350097
Phase3, Recruiting
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
Location: Hackensack NJ, East Brunswick NJ, Montreal, Ottawa,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT04728893
Phase2, Recruiting
Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)
for
PSC
Location: Boston MA, New Haven CT, Montreal, Richmond VA,
Sponsor: PSC Partners Seeking a Cure
Sex: All
Age: 18 - 70+
Code: NCT06297993
Recruiting
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Halifax, Portland ME, Scarborough ME, South Portland ME,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT05554393
Phase2, Recruiting
An Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705
for
Methylmalonic Acidemia
Location: Toronto, Edmonton, San Diego CA, Los Angeles CA,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 1+
Code: NCT05295433
Phase1, Phase2, Recruiting
Early Integration of Palliative and Supportive Care in Cellular Therapy